EULAR 2025: How do risk factors impact progression to Psoriatic Arthritis?
0 SAR
الدفع
المقدمة
هذا الفصل لـ
- Physician
- Resident / Fellow
الفئات ذات الصلة
- EULAR 2025 Symposium Highlights
- Rapid & Sustained efficacy in PsA and axSpA
- Effectiveness of Olumiant vs b-tsDMARDs over 2 years.
- The baricitinib experience –a full review of Olumiant in RA
- Prof. Kleyer–BARE BONE –Olumiant and bone strength in RA.
- Exploring improvements in bone strength in RA with Olumiant.
- Real Patient Experience of Taltz in Psoriasis Arthritis
- Clinical Practice in Treating RA - From Expert to You